Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
The MMR (measles, mumps, rubella) vaccine is one of the most widely studied vaccines in history. Given to virtually every child in the U.S., it generates a substantial number of VAERS reports — but context is essential for interpreting this data.
The following symptoms are most frequently reported after vaccination:
The claimed link between MMR and autism has been extensively studied and debunked. The original 1998 study was retracted and its author lost his medical license for fraud. Multiple large-scale studies involving millions of children have found no connection between MMR vaccination and autism.
VAERS does contain reports mentioning autism after MMR vaccination, but VAERS reports are unverified and cannot establish causation. The timing of MMR vaccination (12-15 months) coincides with when autism symptoms typically become noticeable, creating a temporal correlation that is not causal.
Common (usually mild, resolve in days):
Rare but serious:
MMR is given in two doses in early childhood. See exactly when each is due on the CDC vaccine schedule, review our 2026 vaccine schedule analysis, and explore pediatric VAERS patterns.
As of mid-2026, the MMR vaccine continues to be monitored through VAERS and complementary surveillance systems including the Vaccine Safety Datalink (VSD) and the Clinical Immunization Safety Assessment (CISA) project. No new safety signals have been identified in recent data that would change the established safety profile of this vaccine.
The HHS administration's announced development of AI-powered VAERS analysis tools may provide additional insights into MMR vaccine adverse event patterns. These tools aim to detect subtle signals that traditional statistical methods might miss, though their implementation timeline and methodology remain under development.
It's worth noting that VAERS reporting for routine vaccines like MMR has remained stable through the post-pandemic period. While COVID-19 vaccine reports surged and then declined, reporting patterns for established childhood and adult vaccines have been remarkably consistent, suggesting that the VAERS system continues to function as designed for ongoing safety surveillance.
When interpreting VAERS data for MMR vaccines, several key principles apply:
VAERS data is most useful as a starting point for conversation with your healthcare provider, not as a basis for medical decisions. If you're concerned about MMR vaccine side effects:
For the most up-to-date safety information, consult the CDC's vaccine information pages or speak with a qualified healthcare professional.
As of mid-2026, the MMR vaccine continues to be monitored through VAERS and complementary surveillance systems including the Vaccine Safety Datalink (VSD) and the Clinical Immunization Safety Assessment (CISA) project. No new safety signals have been identified in recent data that would change the established safety profile of this vaccine.
The HHS administration's announced development of AI-powered VAERS analysis tools may provide additional insights into MMR vaccine adverse event patterns. These tools aim to detect subtle signals that traditional statistical methods might miss, though their implementation timeline and methodology remain under development.
It's worth noting that VAERS reporting for routine vaccines like MMR has remained stable through the post-pandemic period. While COVID-19 vaccine reports surged and then declined, reporting patterns for established childhood and adult vaccines have been remarkably consistent, suggesting that the VAERS system continues to function as designed for ongoing safety surveillance.
When interpreting VAERS data for MMR vaccines, several key principles apply:
VAERS data is most useful as a starting point for conversation with your healthcare provider, not as a basis for medical decisions. If you're concerned about MMR vaccine side effects:
For the most up-to-date safety information, consult the CDC's vaccine information pages or speak with a qualified healthcare professional.